Dalian Beigang Biotech Inc.

Northport has acquired a series of Chinese patents focused on health diagnostic applications and products. Northport is now establishing a wholly owned subsidiary corporation, Dalian Beigang Biotech Inc., which will be located in Dalian, China. The company is committed to developing, commercializing and popularizing advanced In Vitro Diagnostic (IVD) kits/devices to improve health of human beings. Its primarily business is to design, develop, patent and market home-applicable diagnostic test papers and portable diagnostic devices related to human cardiovascular diseases.

The company plans to initially develop up to 4 IVD products by the end of 2011 and launch the products into the China marketplace in year 2012. The company projects US$ half million in sales in 2012, US$ 4 million in 2013, and US$ 10 million in revenue in 2014. The company's revenue will be derived mainly from product sales.